These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20565806)

  • 1. SNAI2/Slug promotes growth and invasion in human gliomas.
    Yang HW; Menon LG; Black PM; Carroll RS; Johnson MD
    BMC Cancer; 2010 Jun; 10():301. PubMed ID: 20565806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
    Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
    Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
    Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
    Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC
    Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K; Linskey ME; Bota DA
    Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
    Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
    Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
    J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
    PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
    Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
    Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells.
    Xia H; Cheung WKC; Ng SS; Jiang X; Jiang S; Sze J; Leung GKK; Lu G; Chan DTM; Bian XW; Kung HF; Poon WS; Lin MC
    J Biol Chem; 2012 Mar; 287(13):9962-9971. PubMed ID: 22253443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
    Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
    Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.
    Wang Y; Wang Y; Li J; Zhang Y; Yin H; Han B
    Cancer Lett; 2015 Oct; 367(2):122-8. PubMed ID: 25813405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDA-9/syntenin is a key regulator of glioma pathogenesis.
    Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
    Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
    Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
    Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.
    Méndez O; Zavadil J; Esencay M; Lukyanov Y; Santovasi D; Wang SC; Newcomb EW; Zagzag D
    Mol Cancer; 2010 Jun; 9():133. PubMed ID: 20515450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.